Clinical Trial Update: Recall by Genotype: Neuropeptide Stimulation [Phase 1]

View source ↗

Summary

Phase 1 trial of Recall by Genotype: Neuropeptide Stimulation for reproductive disorders was terminated, and the trial results were posted on 2025-11-18.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reproductive Disorders

Snippet

Sponsor: Stephanie B. Seminara, MD | Conditions: Reproductive Disorder | Phase 1 | Status: TERMINATED | Results posted: 2025-11-18